- Általános
- COVID-19
- Társasági
- Rendezvény
- Hírlevél
| Dokumentum címe |   |
| | | Típus | |
| | | Publikálva |  |
| | | Méret | |
|
Publikus dokumentumok | | Az androgének és az adipociták kölcsönhatása PCOS-ben | |  | pdf |
| | 2022.03.31. | | 0,084 Mb | | | | A 2020. évben azonosított új koronavírus (SARS-CoV-2) okozta fertőzések (COVID-19) megelőzésének és terápiájának kézikönyve (2020.04.11.) | | | pdf |
| | 2020.04.15. | | 0,644 Mb | | | | Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies | | | pdf |
| | 2020.03.09. | | 0,205 Mb | | | | Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV | | | pdf |
| | 2020.03.09. | | 2,328 Mb | | | | Effects of chloroquine on viral infections: an old drug against today’s diseases? | | | pdf |
| | 2020.03.09. | | 0,283 Mb | | | | First Case of 2019 Novel Coronavirus in the United States | | | pdf |
| | 2020.03.09. | | 0,415 Mb | | | | In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine | | | pdf |
| | 2020.03.09. | | 0,328 Mb | | | | Antiviral Treatment Guidelines for Middle East Respiratory Syndrome | | | pdf |
| | 2020.03.09. | | 0,425 Mb | | | | Anti-HIV Effects of Chloroquine (Inhibition of Viral Particle Glycosylation and Synergism With Protease Inhibitors) | | | pdf |
| | 2020.03.09. | | 0,537 Mb | | | | Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus | | | pdf |
| | 2020.03.09. | | 1,902 Mb | | | | 2019 Novel Coronavirus—Important Information for Clinicians | | | pdf |
| | 2020.03.09. | | 0,131 Mb | | | | Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care | | | pdf |
| | 2020.03.09. | | 2,558 Mb | | | | Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov | | | pdf |
| | 2020.03.09. | | 0,417 Mb | | | | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | | | pdf |
| | 2020.03.09. | | 1,231 Mb | | | | The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 | | | pdf |
| | 2020.03.09. | | 3,385 Mb | | | | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro | | | pdf |
| | 2020.03.09. | | 1,298 Mb | | | | Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV | | | pdf |
| | 2020.03.09. | | 1,991 Mb | | | | Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue | | | pdf |
| | 2020.03.09. | | 0,656 Mb | | | | Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China | | | pdf |
| | 2020.03.09. | | 1,169 Mb | | | | Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) | | | pdf |
| | 2020.03.09. | | 1,49 Mb | | | | Table of Therapeutics Appendix 17 February 2020 | | | pdf |
| | 2020.03.09. | | 0,718 Mb | | | | Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking | | | pdf |
| | 2020.03.09. | | 5,84 Mb | | |
|
Ugrás a lap tetejére